Recent Posts
- Egret Therapeutics Announces Appointment Ron Cohen, M.D. to its Board of Directors
- Sable Therapeutics Announces Exclusive Worldwide Licensing Agreement with Columbia University to Develop Novel Polycation Nanomedicines for the Treatment of Obesity
- Terran Biosciences Announces Development of TerXT
- Baudax Bio Acquires TeraImmune, Inc.
- Sable Therapeutics Announces Licensing Agreement with Shanghai Liuqiang Medical Technology Co.
Recent Comments